澳大新語 • 2022 UMAGAZINE 25 29 封面專題 • COVER STORY its advantages in geography and research capacity in biomedical sciences to advance industry-academia collaboration in Chinese medicine. In this way, the university will be able to contribute to the moderate economic diversification of Macao, as well as the development of the GBA into an international centre for technological innovation. With the support of the Macao Economic and Technological Development Bureau and the Science and Technology Development Fund of Macao, the university invited Zhong Nanshan, a member of the Chinese Academy of Engineering with outstanding achievements and contributions in the field of biomedical sciences, to guide the establishment of the institute and serve as president of its steering committee. MITMI will take the development of Chinese medicine and biomedicine as its key task during the initial stage. At the inauguration ceremony for the institute, Lei Wai Nong, secretary for economy and finance of the Macao SAR government, said that the government would provide major support for the institute to transfer research results of Chinese medical sciences, especially those produced by the SKL-QRCM and other UM units. Zhong expressed his hope that MITMI would follow Macao SAR Chief Executive Ho Iat Seng’s instructions to take advantage of the preferential policies for the Guangdong-Macao In-Depth Cooperation Zone in Hengqin and the GBA, and give full play to its role as a bridge between scientific research and industrial transformation, in order to promote the integration of the GBA and the mutual monitoring and recognition of medicines. In the preliminary stage of the institute’s establishment, Zhong and his team organised many mainland pharmaceutical companies to recommend outstanding research results for transfer in Macao. ‘We have selected the first batch of outstanding research results for transfer at the institute,’ says Zhong. ‘The institute will continue to search for research results with great potential from China and abroad and transform them into products in Macao. The institute will also create a mechanism as the foundation of an integrated system for result evaluation, technology transfer, IP-related services, and product registration.’ In addition, one of the major directions of MITMI will be to promote the development of medical and health products. The institute will efficiently promote innovation in medical science and technology, and enhance disease prevention and treatment in the GBA, with the development of innovative Chinese medicine-based drugs as its key mission. According to Prof Song, UM actively draws on the experience of leading research teams from China and abroad to build a stable and effective mechanism for research results transfer. ‘The institute was established in response to the SAR government’s plan. Projects to be promoted include a cancer immunotherapy based on carbon-quantum-dots and a dressing for diabetic foot ulcers developed by UM researchers,’ says Prof Song. ‘The institute will also help cultivate local scientific research results with commercial value, and accelerate their commercialisation in the GBA, so as to promote the industrialisation of Chinese medicine and the expansion of products and services in the field to the global market.’ 澳大校長宋永華 UM Rector Yonghua Song 掃二維碼 觀看訪談片段 Scan the QR code to watch the interview 中國工程院院士鍾南山 Zhong Nanshan, a member of the Chinese Academy of Engineering
RkJQdWJsaXNoZXIy MTQ1NDU2Ng==